JP2020521117A5 - - Google Patents

Download PDF

Info

Publication number
JP2020521117A5
JP2020521117A5 JP2019560086A JP2019560086A JP2020521117A5 JP 2020521117 A5 JP2020521117 A5 JP 2020521117A5 JP 2019560086 A JP2019560086 A JP 2019560086A JP 2019560086 A JP2019560086 A JP 2019560086A JP 2020521117 A5 JP2020521117 A5 JP 2020521117A5
Authority
JP
Japan
Prior art keywords
age
patient
cells
sample
cell surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019560086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521117A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030931 external-priority patent/WO2018204679A1/en
Publication of JP2020521117A publication Critical patent/JP2020521117A/ja
Publication of JP2020521117A5 publication Critical patent/JP2020521117A5/ja
Priority to JP2023064753A priority Critical patent/JP2023098996A/ja
Pending legal-status Critical Current

Links

JP2019560086A 2017-05-04 2018-05-03 診断用終末糖化産物抗体 Pending JP2020521117A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023064753A JP2023098996A (ja) 2017-05-04 2023-04-12 診断用終末糖化産物抗体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762501424P 2017-05-04 2017-05-04
US62/501,424 2017-05-04
US201762610003P 2017-12-22 2017-12-22
US62/610,003 2017-12-22
PCT/US2018/030931 WO2018204679A1 (en) 2017-05-04 2018-05-03 Diagnostic advanced glycation end-product antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023064753A Division JP2023098996A (ja) 2017-05-04 2023-04-12 診断用終末糖化産物抗体

Publications (2)

Publication Number Publication Date
JP2020521117A JP2020521117A (ja) 2020-07-16
JP2020521117A5 true JP2020521117A5 (https=) 2021-06-17

Family

ID=62223287

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560086A Pending JP2020521117A (ja) 2017-05-04 2018-05-03 診断用終末糖化産物抗体
JP2023064753A Pending JP2023098996A (ja) 2017-05-04 2023-04-12 診断用終末糖化産物抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023064753A Pending JP2023098996A (ja) 2017-05-04 2023-04-12 診断用終末糖化産物抗体

Country Status (9)

Country Link
US (1) US20200150131A1 (https=)
EP (1) EP3619540A1 (https=)
JP (2) JP2020521117A (https=)
KR (2) KR20240006702A (https=)
CN (1) CN110832327A (https=)
AU (1) AU2018261622A1 (https=)
CA (1) CA3062082A1 (https=)
IL (1) IL270285B2 (https=)
WO (1) WO2018204679A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010012473A (es) 2008-05-23 2011-02-23 Siwa Corp Metodos, composiciones y aparato para facilitar la regeneracion.
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
CN107001459B (zh) 2014-09-19 2021-11-23 Siwa有限公司 用于治疗炎症和自身免疫紊乱的抗age抗体
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
PT3337829T (pt) 2016-02-19 2020-02-10 Siwa Corp Método e composição para o tratamento do cancro, matando células cancerosas metastáticas e prevenindo as metástases do cancro usando anticorpos para produtos finais de glicação avançada (pga)
CA3057829A1 (en) 2016-04-15 2017-10-19 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
WO2017222535A1 (en) 2016-06-23 2017-12-28 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
CA3059803A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
EP3826670A1 (en) * 2018-07-23 2021-06-02 Siwa Corporation Methods and compositions for treating chronic effects of radiation and chemical exposure
WO2021113152A1 (en) * 2019-12-02 2021-06-10 Viome, Inc. Detection and elimination of aberrant cells
KR20210101481A (ko) * 2020-02-10 2021-08-19 한국과학기술연구원 초음파 출력부를 포함하는 노화세포 제거 장치
US20230181730A1 (en) 2020-05-01 2023-06-15 Siwa Corporation Methods of treating infections
AU2021326232A1 (en) * 2020-08-11 2023-04-13 Shenzhen Protgen Ltd. Young and undamaged human serum albumin improves longevity of human
US20240000930A1 (en) 2020-12-09 2024-01-04 Siwa Corporation Methods and compositions for treating kidney diseases
US20240329058A1 (en) * 2021-04-09 2024-10-03 Gachon University Of Industry-Academic Cooperation Foundation Biomarker for neurodegenerative diseases comprising glycotoxin, specific protein bound to glycotoxin, or glycotoxin-specific protein complex
WO2023023654A1 (en) 2021-08-20 2023-02-23 Siwa Corporation Methods and compositions for treating fibrotic diseases
CN114624362A (zh) * 2022-03-17 2022-06-14 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种检测血清中晚期糖基化终末产物的试剂盒及其应用
CN118562721A (zh) * 2024-06-27 2024-08-30 广州市华代生物科技有限公司 一种基于全皮模型的糖化衰老模型及抗糖效果测试评价方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624804A (en) 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US6380165B1 (en) 1997-09-19 2002-04-30 The Picower Institute For Medical Research Immunological advanced glycation endproduct crosslink
JP4012722B2 (ja) * 2001-11-22 2007-11-21 株式会社トランスジェニック カルボキシメチル化ペプチドに対する抗体
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
MX2010012473A (es) 2008-05-23 2011-02-23 Siwa Corp Metodos, composiciones y aparato para facilitar la regeneracion.
US20110319499A1 (en) * 2008-06-30 2011-12-29 The Johns Hopkins University Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
EP2582293B1 (en) * 2010-06-18 2016-04-20 DiagnOptics Holding B.V. Method and apparatus for determining an autofluorescence value of skin tissue.
US9649376B2 (en) * 2010-09-27 2017-05-16 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
AU2015211021B2 (en) * 2014-01-28 2020-07-02 Buck Institute For Research On Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10639288B2 (en) * 2014-09-12 2020-05-05 The Procter & Gamble Company Anti-aging skin care compositions and regimens
US10358502B2 (en) * 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
BR112018007422A2 (pt) * 2015-10-13 2018-10-30 Siwa Corp anticorpos anti-age e métodos de uso dos mesmos
PT3337829T (pt) 2016-02-19 2020-02-10 Siwa Corp Método e composição para o tratamento do cancro, matando células cancerosas metastáticas e prevenindo as metástases do cancro usando anticorpos para produtos finais de glicação avançada (pga)

Similar Documents

Publication Publication Date Title
JP2020521117A5 (https=)
EP2992332B1 (en) In vitro method for the early detection of a potential inflammation associated with rejection of a transplant
JP2010518386A5 (https=)
JP2013178260A5 (https=)
CN104471406A (zh) 用于诊断骨关节炎的方法
US20160116489A1 (en) Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults
TWI666446B (zh) 皮膚黏彈性的標記物及其利用
JP5969777B2 (ja) 肺腺扁平上皮癌の腫瘍マーカー及び診断キット
RU2445915C1 (ru) Способ прогнозирования риска снижения уровня резистентности организма к острым респираторным заболеваниям у детей в возрасте 3-7 лет по индексу авидности секреторного иммуноглобулина а
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法
EP2581745B1 (en) Composition for diagnosis of lung cancer and diagnosis kit of lung cancer
WO2013016425A2 (en) Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease
JP4825828B2 (ja) 銀染色を用いる電気泳動法により腎疾患等の病態を判定する方法
US20240302365A1 (en) Method for diagnosing chronic urticaria
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
CN103376324A (zh) 白蛋白作为肥胖型糖尿病标志物的应用
CN105807067A (zh) 一种检测阿尔兹海默综合症ncam2的干式免疫荧光试剂盒和制备方法
JP2010181403A (ja) ガンの検出方法とそれに使用されるキット
EP2526423B1 (en) Methods & devices for diagnosing cardiac disorders
JP2000146962A (ja) ストレスの診断方法
WO2025179216A1 (en) Methods and materials to distinguish between active eosinophilic esophagitis (eoe), eoe in remission, and non-eoe states
EP2573569A1 (en) Antibodies, compositions, and assays for detection of cardiac disease
CN113804895A (zh) 尿液免疫球蛋白重链可变区3-7及其多肽片段在烧伤中的应用
CN117147852A (zh) 尿液角蛋白i型细胞骨架18及其多肽片段在过敏性疾病中的应用
CN117147858A (zh) 尿液低亲和力免疫球蛋白γFc区受体III-A及其多肽片段在过敏性疾病中的应用